Abstract 2624: The novel Bruton's tyrosine kinase inhibitor ACP-196 showsin vivoefficacy against human chronic lymphocytic leukemia cells xenografted to the NSG mouse model
Abstract 2624: The novel Bruton's tyrosine kinase inhibitor ACP-196 showsin vivoefficacy against human chronic lymphocytic leukemia cells xenografted to the NSG mouse model
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started